Evidence map›Paper›PMID 42569397›Full record

ArticleKidney international reports2026

Long Term Outcomes in Living Kidney Donors Over 30 Years.

Joana Krättli, Deborah Buess, Marie Flohr, Matthias Diebold, Caroline Wehmeier, Daniel Sidler, Guido Beldi, Dela Golshayan, Tobias Zingg, Sophie de Seigneux and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Joana KrättliSwiss Organ Living-Donor Health Registry (SOL-DHR), University Hospital Basel, Basel, Switzerland.
Deborah BuessSwiss Organ Living-Donor Health Registry (SOL-DHR), University Hospital Basel, Basel, Switzerland.
Marie FlohrSwiss Organ Living-Donor Health Registry (SOL-DHR), University Hospital Basel, Basel, Switzerland.
Matthias DieboldDepartment of Circulation, Thorax and Transplantation, Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
Caroline WehmeierDepartment of Circulation, Thorax and Transplantation, Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
Daniel SidlerDepartment for Nephrology and Hypertension, University Hospital Insel, Berne, Switzerland.
Guido BeldiDepartment of Visceral Surgery and Medicine, University Hospital Insel, Abdominal Center Berne, Switzerland.
Dela GolshayanDepartment for Medicine, Transplantation Center, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Tobias ZinggDepartment of Visceral and Transplant Surgery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Sophie de SeigneuxNephrology and Hypertension Division, University Hospital Geneva (HUG), Geneva, Switzerland.
Fadi HaidarNephrology and Hypertension Division, University Hospital Geneva (HUG), Geneva, Switzerland.
Alexander RitterClinic for Nephrology and Transplantation Medicine, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Isabelle BinetClinic for Nephrology and Transplantation Medicine, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Kerstin HübelDivision of Nephrology, University Hospital Zurich, Zurich, Switzerland.
Fabian RösslerDepartment of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
Jürg SteigerSwiss Organ Living-Donor Health Registry (SOL-DHR), University Hospital Basel, Basel, Switzerland.
Patricia Hirt-MinkowskiSwiss Organ Living-Donor Health Registry (SOL-DHR), University Hospital Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Living kidney donor transplantation provides major benefits for recipients, but long-term donor safety remains a critical concern. Methods: We conducted a prospective, multicenter cohort study using data from the Swiss Organ Living-Donor Health Registry. A total of 1863 living kidney donors (1993-2018) with ≥ 5 years of follow-up were followed until death, kidney failure (KF), or last visit (censoring March 31, 2024). Kidney function trajectories from 12 months postdonation onward were analyzed using linear mixed-effects models. A composite secondary end point included early death, dialysis-dependent KF, estimated glomerular filtration rate (eGFR) < 30 ml/min per 1.73 m Results: A total of 1863 living kidney donors (median age 53 years, 66.2% female) were included; 15.5% had treated arterial hypertension before donation. Median predonation eGFR was 96 ml/min per 1.73 m Conclusion: These findings support safety while underscoring the need for standardized long-term surveillance to optimize donor care and counseling.

Indexed as

donor safetykidney function declineliving kidney donationliving kidney donorslong-term outcomespostdonation monitoring

Identifiers

PMID42569397
PMCPMC13449912

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.